Rhumbline Advisers Has $4.41 Million Stake in Roche Holding AG (OTCMKTS:RHHBY)

Rhumbline Advisers raised its holdings in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 7.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 107,252 shares of the company's stock after acquiring an additional 7,374 shares during the quarter. Rhumbline Advisers' holdings in Roche were worth $4,413,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of RHHBY. GAMMA Investing LLC grew its holdings in Roche by 6,463.8% during the first quarter. GAMMA Investing LLC now owns 528,778 shares of the company's stock valued at $21,759,000 after purchasing an additional 520,722 shares during the period. Boston Common Asset Management LLC grew its holdings in shares of Roche by 10.0% in the 1st quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company's stock valued at $13,369,000 after buying an additional 29,522 shares during the period. Confluence Investment Management LLC increased its position in shares of Roche by 3.6% in the 1st quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock valued at $596,000 after buying an additional 510 shares in the last quarter. Minot DeBlois Advisors LLC acquired a new stake in Roche during the 4th quarter worth $752,000. Finally, Hancock Whitney Corp lifted its holdings in Roche by 6.8% during the fourth quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock worth $820,000 after acquiring an additional 1,496 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on RHHBY. HSBC downgraded Roche from a "buy" rating to a "hold" rating in a report on Monday, April 28th. Hsbc Global Res downgraded shares of Roche from a "strong-buy" rating to a "hold" rating in a report on Monday, April 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, one has given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy".

Roche Trading Down 0.3%

Shares of Roche stock traded down $0.14 during trading on Tuesday, reaching $40.02. The stock had a trading volume of 1,312,709 shares, compared to its average volume of 1,172,179. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.20 and a current ratio of 1.48. The stock has a fifty day moving average price of $39.63 and a two-hundred day moving average price of $39.11. Roche Holding AG has a 52 week low of $33.76 and a 52 week high of $44.31.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.